As COVID-19 continues to surge, cancer scientists engaged in basic research face unique challenges. At centers throughout the United States, investigators are confronting difficult decisions about which experiments to continue, while securing supplies and creating contingency plans for a complete shutdown.
keywords
author
year ⏰ 2020
issn 🗄
volume
number
page
citedbycount 0
download 🔖 [BibTeX]